| Literature DB >> 34104511 |
Hüseyin Kuplay1, Sevinç Bayer Erdoğan1, Murat Baştopçu1, Eren Karpuzoğlu1, Halit Er1.
Abstract
BACKGROUND: We aimed to investigate the predictive value of Society of Thoracic Surgeons (STS) and European System for Cardiac Operative Risk Evaluation (EuroSCORE II) scores for mortality in octogenarian cardiac surgery patients.Entities:
Keywords: Cardiac surgery; mortality; octogenarian; risk scores
Year: 2021 PMID: 34104511 PMCID: PMC8167478 DOI: 10.5606/tgkdc.dergisi.2021.21403
Source DB: PubMed Journal: Turk Gogus Kalp Damar Cerrahisi Derg ISSN: 1301-5680 Impact factor: 0.332
Demographic and operative characteristics of octogenarian patients (n=116)
| n | % | Mean±SD | Median | IQR | |
| Age (year) | 82.9±3.1 | ||||
| Sex | |||||
| Male | 73 | 62.9 | |||
| Female | 43 | 37.1 | |||
| Body mass index (kg/m2) | 28.5±4.7 | ||||
| Body mass index (n=95) | |||||
| Normal | 27 | 28.4 | |||
| Overweight | 32 | 33.7 | |||
| Obese class I | 24 | 25.3 | |||
| Obese class II | 12 | 12.6 | |||
| Operation | |||||
| Elective | 89 | 76.7 | |||
| Urgent | 27 | 23.3 | |||
| Operation type | |||||
| CABG | 65 | 56.0 | |||
| Mitral valve surgery | 20 | 17.2 | |||
| Aortic valve surgery | 10 | 8.6 | |||
| Aortic valve surgery + CABG | 16 | 13.8 | |||
| Mitral valve surgery + CABG | 5 | 4.3 | |||
| Diabetes mellitus | 54 | 46.6 | |||
| Hypertension | 52 | 44.8 | |||
| Preoperative pulmonary artery pressure | 30.9±13.1 | ||||
| Pulmonary hypertension | |||||
| Normal | 68 | 58.6 | |||
| Moderate | 42 | 36.2 | |||
| Severe | 6 | 5.2 | |||
| Cardiopulmonary bypass time | 118.6±37.4 | ||||
| Aortic cross clamp time | 85 | 64-118 | |||
| Creatinine clearance | 62.3±17.7 | ||||
| Preoperative ejection fraction | 51.6±9.7 | ||||
| Preoperative ejection fraction (n=110) | |||||
| Normal | 63 | 57.3 | |||
| Moderate | 40 | 36.4 | |||
| Low | 7 | 6.4 | |||
| Peripheral arterial disease | 2 | 1.8 | |||
| History of stroke | 3 | 2.6 | |||
| Postoperative stroke | 7 | 6.0 | |||
| Postoperative renal failure | 16 | 13.8 | |||
| Postoperative infection | 12 | 10.3 | |||
| Reoperation | 30 | 25.9 | |||
| Mechanical ventilation time (days) | 1 | 1-2 | |||
| Length of stay in the intensive care | 2 | 1-3 | |||
| Total length of stay | 7 | 6-12 | |||
| EuroSCORE II | 5.2±5.4 | ||||
| Society of thoracic surgeons | 3.7±11.1 | ||||
| Mortality | 32 | 27.6 | |||
| SD: Standard deviation; IQR: Interquartile range; CABG: Coronary artery bypass grafting. | |||||
Comparison of patient characteristics according to mortality
| No mortality (n=84) | Mortality (n=32) | ||||||||||
| n | % | Mean±SD | Median | IQR | n | % | Mean±SD | Median | IQR | ||
| Age (year) | 82.4±2.5 | 84.1±4.1 | 0.030 | ||||||||
| Sex | |||||||||||
| Female | 30 | 35.7 | 13 | 40.6 | 0.625 | ||||||
| Body mass index (kg/m2) | 28.3±4.6 | 29.4±4.5 | 0.351 | ||||||||
| Body mass index (n=95) | 0.836 | ||||||||||
| Normal | 24 | 32.0 | 5 | 25.0 | |||||||
| Overweight | 25 | 33.3 | 5 | 25.0 | |||||||
| Obese class I | 17 | 22.7 | 7 | 35.0 | |||||||
| Obese class II | 9 | 12.0 | 3 | 15.0 | |||||||
| Operation | 0.006 | ||||||||||
| Elective | 70 | 94.6 | 19 | 59.4 | |||||||
| Urgent | 14 | 16.7 | 13 | 40.6 | |||||||
| Operation type | 0.023 | ||||||||||
| CABG | 53 | 63.1 | 12 | 37.5 | |||||||
| Mitral valve surgery | 14 | 16.7 | 6 | 18.8 | |||||||
| Aortic valve surgery | 4 | 4.8 | 6 | 18.8 | |||||||
| Aortic valve surgery + CABG | 11 | 13.1 | 5 | 15.7 | |||||||
| Mitral valve surgery + CABG | 2 | 2.4 | 3 | 9.4 | |||||||
| Diabetes mellitus | 33 | 39.3 | 21 | 65.7 | 0.011 | ||||||
| Hypertension | 34 | 40.5 | 18 | 56.3 | 0.127 | ||||||
| Preoperative pulmonary artery pressure | 30.0±12.3 | 33.4±15.0 | 0.209 | ||||||||
| Pulmonary hypertension | 0.070 | ||||||||||
| Normal | 49 | 58.3 | 19 | 59.4 | |||||||
| Moderate | 33 | 39.3 | 9 | 28.1 | |||||||
| Severe | 2 | 2.4 | 4 | 12.5 | |||||||
| Cardiopulmonary bypass time | 115.7±35.8 | 126.2±40.9 | 0.176 | ||||||||
| Aortic cross clamp time | 81 | 58-118 | 85 | 75-126 | 0.172 | ||||||
| Creatinine clearance | 65.3±15.4 | 54.4±20.9 | |||||||||
| Preoperative ejection fraction | 52.3±9.5 | 49.3±10.0 | 0.152 | ||||||||
| Preoperative ejection fraction (n=110) | 0.396 | ||||||||||
| Normal | 50 | 59.5 | 13 | 46.4 | |||||||
| Moderate | 27 | 32.1 | 13 | 46.4 | |||||||
| Low | 5 | 59.5 | 2 | 6.3 | |||||||
| Peripheral arterial disease | 2 | 2.4 | 0 | 0 | 0.999 | ||||||
| History of stroke | 3 | 3.6 | 0 | 0 | 0. 565 | ||||||
| Postoperative stroke | 4 | 4.8 | 3 | 9.4 | 0.377 | ||||||
| Postoperative renal failure | 4 | 4.8 | 12 | 37.5 | |||||||
| Postoperative infection | 5 | 6.0 | 7 | 21.9 | |||||||
| Reoperation | 13 | 15.5 | 17 | 53.1 | |||||||
| Mechanical ventilation time (days) | 1 | 1.1 | 2 | 1.5 | |||||||
| Length of stay in the intensive care | 1 | 1.2 | 2 | 1.5 | |||||||
| Total length of stay | 7.5 | 7-12 | 4 | 1-10.5 | |||||||
| SD: Standard deviation; IQR: Interquartile range; CABG: Coronary artery bypass grafting. | |||||||||||
STS and EuroSCORE II according to mortality
| No mortality (n=84) | Mortality (n=32) | ||||
| Mean±SD | Mean±SD | ||||
| All patients (n=116) | STS | 3.0±8.7 | 5.4±15.8 | 0,423 | |
| EuroSCORE II | 4.1±4.0 | 8.1±7.4 | 0,006 | ||
| Operation | Elective (n=89) | STS | 3.2±9.5 | 7.7±20.3 | 0,165 |
| EuroSCORE II | 3.7±3.9 | 7.2±7.3 | 0,006 | ||
| Urgent (n=27) | STS | 2.1±0.9 | 2.0±1.0 | 0,869 | |
| EuroSCORE II | 6.3±4.2 | 9.5±7.5 | 0,181 | ||
| Operation type | CABG (n=65) | STS | 1.8±0.9 | 1.8±0.7 | 0,947 |
| EuroSCORE II | 4.2±4.3 | 6±6.3 | 0,231 | ||
| Mitral valve surgery (n=20) | STS | 7.6±21.1 | 16.6±35.6 | 0,489 | |
| EuroSCORE II | 2.5±1.0 | 11.5±11.2 | 0,006 | ||
| STS | 2.6±1.3 | 2.5+1.0 | 0,848 | ||
| Aortic valve surgery (n=10) | EuroSCORE II | 5.2±3.9 | 11.2±8.6 | 0,233 | |
| Aortic valve surgery + CABG (n=16) | STS | 3.3±1.7 | 2.3±1.3 | 0,26 | |
| EuroSCORE II | 4.7±3.9 | 6.1±2.9 | 0,494 | ||
| Mitral valve surgery + CABG (n=5) | STS | 3.0±2.0 | 8.7±12.5 | 0,585 | |
| EuroSCORE II | 8.3±9.4 | 7.1 ±2.5 | 0,832 | ||
Observed and predicted mortality rates
| % | Mean±SD | |||
| All patients (n=116) | STS | 5.40±15.8 | ||
| EuroSCORE II | 8.1 ±7.34 | |||
| Observed | 276 | |||
| Timing of operation | Elective (n=89) | STS | 7.7±20.3 | |
| EuroSCORE II | 7.2±7.3 | |||
| Observed | 21,3 | |||
| Urgent (n=27) | STS | 2.0±1.0 | ||
| EuroSCORE II | 9.5±7.5 | |||
| Operation type | Observed | 48,1 | ||
| CABG (n=65) | STS | 1.8±0.8 | ||
| EuroSCORE II | 4.5±4.8 | |||
| 18,5 | ||||
| Mitral valve surgery (n=20) | STS | 6.3±176 | ||
| EuroSCORE II | 5.2±7.2 | |||
| Observed | 30 | |||
| Aortic valve surgery (n=10) | STS | 2.5±1.0 | ||
| EuroSCORE II | 9.4±7.7 | |||
| Observed | 60 | |||
| Aortic valve + CABG (n=16) | STS | 3.0±1.7 | ||
| EuroSCORE II | 5.3±3.6 | |||
| Observed | 33,3 | |||
| Mitral valve + CABG (n=5) | STS | 6.4±9.4 | ||
| EuroSCORE II | 75±5.1 | |||
| 60 | ||||
| SD: Standard deviation; STS: Society of thoracic surgeons; EuroSCORE II: European System for Cardiac Operative Risk Evaluation II; CABG: Coronary artery bypass grafting. | ||||
Figure 1ROC curves for EuroSCORE II and STS score for mortality in all cardiac operations.
ROC: Receiver operating characteristic; STS: Society of Thoracic Surgeons; EuroSCORE II: European System for Cardiac Operative Risk Evaluation II.
ROC analyses for EuroSCORE II and STS score for mortality in octogenarian patients
| AUC | 95% CI | |||||
| All operations | STS | 0,537 | 0.422-0.631 | 0,554 | 0,003 | |
| EuroSCORE II | 0,754 | 0.665-0.829 | <0.001 | |||
| Timing of operation | Elective | STS | 0,584 | 0.443-0.726 | 0,243 | 0,692 |
| EuroSCORE II | 0,761 | 0.644-0.877 | <0.001 | |||
| Urgent | STS | 0,524 | 0.281-0.766 | 0,848 | 0,058 | |
| EuroSCORE II | 0,615 | 0.392-0.838 | 0,31 | |||
| ROC: Receiver operating characteristic; EuroSCORE II: European System for Cardiac Operative Risk Evaluation II; STS: Society of thoracic surgeons; AUC: Area under the curve; CI: Confidence interval. | ||||||